| Tag | Content |
|---|
EnhancerAtlas ID | HS105-64857 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr5:95590230-95592260 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOXC1 | MA0032.2 | chr5:95591876-95591887 | ATATTTACATA | - | 6.62 | | JUN(var.2) | MA0489.1 | chr5:95590791-95590805 | ATGACTCATATTCT | - | 6.1 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_39210 | chr5:95589407-95592050 | IMR90 | | SE_45921 | chr5:95589525-95596006 | Osteoblasts | | SE_51855 | chr5:95589753-95591917 | Skeletal_Muscle_Myoblast | | SE_63657 | chr5:95589753-95591931 | HSMM | | SE_63657 | chr5:95592032-95592451 | HSMM |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr5 | 95590348 | 95591807 | | chr5 | 95590629 | 95591510 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH05I096253 | chr5 | 95589556 | 95596286 |
|
Enhancer Sequence | CAATATTCCT TTCTTATTTA ATTCCTACTT CCATGTCTAC ATTTTAAAAA GTGGTTCCTA 60
TATTCAGGAG TAATTTATTA CTTAGCTCTT GAGAGAGAAA GGTGGCTATG TATGTACATT 120
TTCTTAAAAT GTGCTTTGAA TTTTACTCCA GGGACAGTGG TTGAAATCTT GCCCAGAGTT 180
ATCATGTTAG TTACAAAGTA GACATGGACT GATGTATGAC AGGAGAAGAG TTTCTGATAT 240
CAGGAATATT TGATTTTATT TTGGAATAGG TGAAGATTGA GGGTTTTAAA AAAATTTCTG 300
TCTTTAAGAA TTTCCCATTA AAACACTATT TTTTAAATCT GTATCCAGAG CTGGAATTTT 360
ATATTGCTAA AAGTATTACA GCCTATTCTC ACTTTTATTC TCCTTTGTCG GGCATATTTG 420
CTCATGTCTA AGTCTTTTCA GTTATTCTTA ATCCTACTTA AAATCTTTGG GTGGATTAAA 480
AGTTGCATTT CCTTGTAGCT TATGTTGCAA GCATCAAATG ATTAAAAAAC GAAGATAATT 540
TATTTTCCTA CCATAAGCTT AATGACTCAT ATTCTGGAGC GGATGGGGGT TGGCAGGGGG 600
AAGAAGGGAG GCAAAGAAAA GTAAAAAGTA AATAGCAGGC ATGTTTCAGG AGAAACTCCA 660
GCCAGGGCTG TTGGGTTGAA CTTTATCGAT GCTGCTTCAT GATATGTGTC AAAATAAATG 720
CAGGAAACAG CTTTTGCCTC AAAGCTTGGA ATGTTGTGGT TAACTGATAT TTAGGTAAAG 780
GAATGTTACA ATTGGAATAG CTGGCCTAAA ACTCTTCCCA AAACCATCAA TTTTATTTAT 840
TAAACTTGCT GAAAAGACGA AAAGTGACAA GGAAAGGCAC AGATCATTTA TTTATTTGAC 900
AAGTTTCTCA GAGTTCTTTT CCTTGATAAA GCAGCAATGA CGATGAATTT TATTATGCTT 960
AGTGTATGTG TTTGCTTGGT TTAAATTATT TACATATTTA CTGTTAGGGC AGTAATAAAA 1020
CCAGGTCAGT CCAAATAACT TTTTTTTTGT CTTGTCTGTG GAACACTATG AAAGTTGCAT 1080
TTTTAATGGA TGATGACCAC AGTTGTTTTT AGGATTCCTG AATGAAGTCA TGAAGTCTGA 1140
AAAATTTTGG AACCTAGAGT TTTAACTCAT GTTACAATTT GAGTAACTGC TTTACAGAAA 1200
AGGGCCTGGT CTAATTTTGA GACTGTGGCT TGATTCTCAC AAGTTTGATG CTCATTTCCC 1260
AAGGATAATA TATATAAGCC CATAATTAAG GCTGTACTTT AGTTAGACTT GAGTTGTGAA 1320
GAAAGAAATT CAGGTTACTT TAGGGTTCCG TTCCTCAAAT CTGGTGTTCT GTGCTATGCT 1380
TTTACAGTTA AGTGTGCTAC AAAATAAAGT CTTTGGGACC CTCTGTTAAA TAGGTTTAAA 1440
CTTTTTTGGA ACAAGATTTC TAAGAGACTT AAATGTGCAA GAGAGCATTC TGACTGAGAA 1500
AGGATAAGGC ATGTAGCATT TCCAGATCAT TAGCAAGCAG TATCTATTCT CATCTCTCAG 1560
AACTCTGTTT CTCAGAGCAT GGTTAAGGAG AATTTTTATG TATATAAATG TATCACCATC 1620
AATAATCAAG GCAGAACTGT ATATTTATAT TTACATAGTA TATATTACAT ATTATATATA 1680
AACTTACATA TATATTATAT AAACATATAA TTTATACAGT ATTTATGTGT TTATATGTAA 1740
TATGTAATAT ATACTATATA AATATACAGT TTATACAGTA TATTTGTGTG ATATAAATAT 1800
ACGGTATATA AATATATAAA TATACAGTAT ATAAATATAC AGTAATATAT ATATATACTA 1860
TATAAATATA CAGTTATGCC TTGCTTATTA ATGATGATAC ATTCTGAGAA ATGTGTCATT 1920
AGGCAATTTT GTCATTGTGC TAACATCATA TTTTGTATTT ACACAAAATT AGATGGTATA 1980
GTCTGCTATG TGGGTAGGCT ATATTATAAA ACCTATTGCT CCTAGGCTAC 2030
|
